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Abstract
The actions of thyroid hormone (TH) on pancreatic beta cells have not been thoroughly explored, with current knowledge be-
ing limited to the modulation of insulin secretion in response to glucose, and beta cell viability by regulation of pro-mitotic and 
pro-apoptotic factors. Therefore, the effects of TH on proinsulin gene expression are not known. This led us to measure: a) 
proinsulin mRNA expression, b) proinsulin transcripts and eEF1A protein binding to the actin cytoskeleton, c) actin cytoskeleton 
arrangement, and d) proinsulin mRNA poly(A) tail length modulation in INS-1E cells cultured in different media containing: i) 
normal fetal bovine serum - FBS (control); ii) normal FBS plus 1 µM or 10 nM T3, for 12 h, and iii) FBS depleted of TH for 24 h 
(Tx). A decrease in proinsulin mRNA content and attachment to the cytoskeleton was observed in hypothyroid (Tx) beta cells. 
The amount of eEF1A protein anchored to the cytoskeleton was also reduced in hypothyroidism, and it is worth mentioning that 
eEF1A is essential to attach transcripts to the cytoskeleton, which might modulate their stability and rate of translation. Proinsulin 
poly(A) tail length and cytoskeleton arrangement remained unchanged in hypothyroidism. T3 treatment of control cells for 12 h 
did not induce any changes in the parameters studied. The data indicate that TH is important for proinsulin mRNA expression 
and translation, since its total amount and attachment to the cytoskeleton are decreased in hypothyroid beta cells, providing 
evidence that effects of TH on carbohydrate metabolism also include the control of proinsulin gene expression. 
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Thyroid hormone (TH) is known to modulate develop-
mental and metabolic processes by interacting with specific 
binding sites located in the nucleus, cytoplasm, organelles, 
and plasma membrane (1-5). It is well known that TH af-
fects the metabolic rate by controlling lipid, protein and 
carbohydrate synthesis and degradation (6,7), actions that 
are also shared by insulin and growth hormone (GH) (8-11). 
Besides, TH is known to induce GH gene expression, which 
might indirectly account for its metabolic effects. 
On the other hand, the action of TH on insulin gene 
expression remains uncertain, as the available data are 
scarce and sometimes conflicting. Indeed, one study has 
shown that T3 enhances proinsulin mRNA levels during 
pancreatic beta cell differentiation from the human duct 
cell line (hPANC-1), whereas other studies have shown the 
opposite effects, that is, T3 and T4 leading to a decrease 
in proinsulin gene expression in RIN-m5F cells and rat 
pancreatic beta cells, respectively (12-14). 
The regulation of insulin gene expression is an important 
step in carbohydrate metabolism, and even though several 
hormones have been shown to modulate it (15-17), the 
participation of TH in this process has been poorly explored. 
In fact, hyperthyroid and hypothyroid states have been as-
sociated with the impairment of glucose homeostasis, which 
might alter insulin synthesis and release, blunting a possible 
direct effect of TH on the proinsulin gene expression. More-
over, recent evidence that TH might post-transcriptionally 
regulate the expression of certain genes indicates that it 
can rapidly interfere with the stability and translation rate of 
distinct mRNAs (18,19). This could be another mechanism 
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by which TH could affect proinsulin gene expression, which 
has never been investigated.
In fact, the post-transcriptional control of gene expres-
sion by TH includes effects on mRNA polyadenylation, which 
could be enhanced or decreased, increasing or decreasing 
transcript stability and translation rate, as shown for GH 
mRNA and TSH mRNA, respectively (18,19). In addition, 
it is known that the poly(A) tail of the transcripts plays an 
important role in their attachment to the cytoskeleton, which 
would also help to protect them from RNases, leading to 
repercussion on their half-lives (20).
The transcript attachment to the cytoskeleton is medi-
ated by specific proteins, which recognize binding sites 
in mRNA molecules and simultaneously in proteins of 
the cytoskeleton. Despite the fact that several proteins 
have already been identified as mediators of this binding 
process, the eukaryotic elongation factor 1 A (eEF1A), a 
primary protein involved in protein synthesis, has been 
shown by Liu et al. (21) to be able to attach transcripts to 
the cytoskeleton. 
Therefore, the present study attempted to investigate in 
INS-1E cells the effects of TH on proinsulin gene expres-
sion, and its possible post-transcriptional effects on: a) 
proinsulin transcript poly(A) tail length and attachment to the 
cytoskeleton, b) eEF1A protein binding to the cytoskeleton, 
and c) cytoskeleton organization. Taken together, these data 
should provide insight into the control of proinsulin gene 
expression by TH, and strengthen the existing evidence for 
the metabolic actions of TH. 
Material and Methods
Material
Triiodo-L-thyronine (T3), Triton X-100, L-glutamine, 
and anti-ß-actin antibody were purchased from Sigma 
Chemical Co. (USA). The anti-α-actinin antibody was 
purchased from Santa Cruz Biotechnology, Inc. (USA), 
and anti-EF1A was purchased from Upstate Biotechnol-
ogy Inc. (USA). Phenol, guanidine isothiocyanate, sodium 
N-lauryl sarcosine, diethyl pyrocarbonate (DEPC), aga-
rose, N-morpholino-propanesulfonic acid buffer (MOPS), 
sodium dodecyl sulfate, ethidium bromide, BSA, oligo(dT) 
and dNTP, RNase-free DNase I, DNA ladder, HEPES, and 
ß-mercaptoethanol were purchased from Invitrogen Life 
Technologies, Inc. (USA). The anti-mouse and anti-rabbit 
horseradish peroxidase antibodies were purchased from 
Jackson Laboratories (USA). Rhodamine-phalloidin was 
purchased from Molecular Probes (USA). Reverse tran-
scriptase (M-MLV), 5X First-Strand buffer, GoTaq® DNA 
Polymerase and 5X Green GoTaq® Flexi Buffer were pur-
chased from Promega (USA). SYBR® Green PCR master 
mix was purchased from Applied Biosystems (USA). The 
enhanced chemiluminescence (ECL) kit, protein molecular 
weight markers and the Bio-Rad protein assay kit were 
purchased from Bio-Rad Laboratórios Brasil Ltda. (Brazil). 
Heat-inactivated fetal bovine serum (FBS), phosphate-
buffered saline, trypsin/EDTA solution, RPMI 1640 culture 
medium, and sodium pyruvate were purchased from Vitrocell 
Comércio de Produtos para Laboratórios Ltda. (Brazil). 
Tissue culture materials were purchased from TPP Techno 
Plastic Products AG (Switzerland). All other reagents were 
purchased from Labsynth (Brazil). 
Cell culture 
The rat INS-1E insulinoma cell line was kindly provided 
by Prof. Ângelo Rafael Carpinelli (Universidade de São 
Paulo, São Paulo, SP, Brazil) and cultured in RPMI 1640 
with 11 mM glucose, supplemented with 10% FBS, 10 mM 
HEPES, 1 mM sodium pyruvate, 2 mM L-glutamine, 50 U/
mL penicillin, 50 µg/mL streptomycin, and 50 µm 2-mercap-
toethanol. Cells were cultured between passages 63-72 and 
were grown at 37°C in 95% humidified air with 5% CO2. 
Cells were used for experiments at 80-90% confluence. To 
perform the experiments, the cells were maintained in a) 
normal FBS (control group), b) normal FBS plus 1 µM or 
10 nM T3, for 12 h, and c) FBS depleted from TH, for 24 
h (Tx group). The following parameters were then evalu-
ated: a) proinsulin gene expression by real-time PCR, b) 
proinsulin transcripts and eEF1A protein attached to the 
actin cytoskeleton, c) actin cytoskeleton rearrangement 
by actin fractionation, and d) proinsulin mRNA poly(A) tail 
length by rapid amplification of cDNA ends - poly(A) test 
(RACE-PAT). TH depletion from FBS was carried out ac-
cording to Hollenberg et al. (22).
Cell viability assay
INS-1E cells (1 x 106 cells/mL) were resuspended in 
300 µL PBS and 30 µL propidium iodide solution (20 µg/
mL in PBS) was added. The percentage of viable cells in 
each sample was determined using a FACSCalibur flow 
cytometer (Becton-Dickinson, USA). The flow cytometer 
was frequently checked, calibrated and tested for quality 
control. Propidium iodide is a highly water-soluble fluores-
cent compound that cannot pass through intact membranes, 
and is generally excluded from viable cells. It binds to 
DNA by intercalating between the bases with little or no 
sequence preference. Fluorescence was measured using 
the FL2 channel (Orange-red fluorescence-585/42 nm). Ten 
thousand events were analyzed per experiment. Cells with 
propidium iodide fluorescence were then evaluated using 
the Cell Quest software (Becton-Dickinson) (23).
Measurement of proinsulin gene expression by 
real-time PCR 
Total RNA was extracted by the guanidine-phenol-chlo-
roform method described by Chomczynski and Sacchi (24) 
and quantified by spectrophotometry. Samples were treated 
with RNase-free DNase I (Invitrogen), and 1 µg RNA was 
reverse-transcribed in a reaction containing oligo(dT) (100 
µg/mL), 10 mM dNTP, 5X First-Strand buffer, and 2 µL 200 
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U M-MLV reverse transcriptase (Invitrogen). For real-time 
PCR amplification, 2 µL of each reverse transcription (RT) 
product was diluted in 200 µL DEPC water, and 1 µL was 
added to a reaction buffer containing 5 µL SYBR® Green 
PCR master mix (Applied Biosystems) and 900 nM primers, 
in a final volume of 12.5 µL per sample. The sequences of 
the primers used are listed in Table 1 and were designed 
using the Primer-BLAST tool. The reaction conditions 
consisted of two steps at 50°C for 2 min and at 95°C for 2 
min, followed by 45 cycles of three steps: 15 s denaturation 
at 95°C, 60 s annealing at 60°C, and 15 s at 72°C. The 
threshold cycle (CT) of the real-time PCR was measured 
in duplicate for each sample. The CT value represents the 
PCR cycle number at which the increasing fluorescence 
intensity of amplified RT-PCR products of the target gene 
is exponential, and is inversely correlated with the amount 
of the target mRNA in the sample. A ∆CT value was calcu-
lated for each sample by subtracting the CT value of the 
reference gene from the CT value of the gene of interest. 
To reduce interassay variation, all samples were normal-
ized to the ∆CT value of a control sample, the calibrator 
one, derived from the same control, for all assays (∆∆CT). 
The relative expression of mRNAs was calculated using 
the 2-∆∆CT method, and is reported as arbitrary units (AU). 
The reference gene used for real-time PCR was RPL19, 
which presented the most uniform expression in response 
to different treatments.
Measurement of proinsulin mRNA poly(A) tail length 
by RACE-PAT
Proinsulin mRNA poly(A) tail length was measured by the 
RACE-PAT according to a standard protocol (25,26). Briefly, 
200 ηg of an oligo(dT) anchor (5’-GCGAGCTCCGCGGCC 
GCG-T12) was added to 2 µg total RNA in a sterile RNase-
free microfuge tube. The samples were denatured at 65°C 
for 5 min, transferred to 42°C and reverse-transcribed for 
60 min using a mix containing 10 mM of each dNTP, 5X 
First-Strand buffer, 10 mM DTT, 1 µL reverse transcriptase 
M-MLV (Invitrogen). Inactivation was performed at 70°C for 
15 min. Three microliters of the RT reaction product was 
mixed with a reaction buffer containing 25 mM MgCl2, 10 
mM of each dNTP, 25 pmol of each primer sense (Table 1), 
1.25 U of GoTaq® DNA Polymerase and 5X Green GoTaq® 
Flexi Buffer (Promega). The reaction was performed for 
40 cycles, each consisting of 95°C for 30 s (denaturation), 
64°C for 1 min (annealing), and 72°C for 1 min (exten-
sion), followed by a final 7-min elongation step at 72°C. 
The PCR-amplified products were analyzed by denaturing 
2.5% agarose gel electrophoresis and ethidium bromide 
staining. Amplicon sizes were estimated by densitometry 
and compared with a 100-bp DNA ladder (Invitrogen Life 
Technologies) using the ImageQuant TL software (Version 
2005 Amersham Biosciences, USA). The top of the smear 
indicates the longest amplified fragment, which represents 
the poly(A) tail size plus 405 bases upstream, according to 
the proinsulin primer used. The changes in poly(A) tail length 
were detected by analyzing the length of cDNA smears 
obtained in all experimental groups studied.
Measurement of polymerized (F) and non-polymerized 
(G) actin content by Western blotting analysis 
Actin fractionation. The protocol was adapted from 
Posern et al. (27), Haller et al. (28), who included phalloidin 
in the lysis buffer described by Posern, and Liu et al. (21), 
who evaluated eEF1A binding to the actin cytoskeleton. 
Cells were lysed in 0.75 mL lysis buffer containing 50 mM 
NaCl, 1 mM EDTA, 0.5% Triton X-100, 20 mM HEPES, 
pH 7.9, and 132 nM phalloidin, a fungal toxin that specifi-
cally binds to polymerized actin (F-actin) and protects it 
from depolymerization. After 10 min, the homogenate 
was centrifuged at 100,000 g for 30 min at 4°C, and the 
supernatant (non-polymerized actin) and pellet fractions 
(polymerized actin) were obtained. The pellet, which con-
tains the F-actin fraction, was resuspended in 0.2 mL actin 
lysis buffer and then sonicated. The amount of proteins in 
the pellet and supernatant was determined by the method 
of Bradford (29).
Measurement of proinsulin transcripts and eEF1A 
binding to F-actin 
In order to determine the amount of eEF1A and pro-
insulin mRNA bound to F-actin, the INS-1E cells were 
lysed in 0.75 mL lysis buffer containing 50 mM NaCl, 1 
mM EDTA, 0.5% Triton X-100, 20 mM HEPES, pH 7.9, 
and 132 nM phalloidin. G- and F-actin were separated by 
ultracentrifugation at 100,000 g for 30 min at 4°C. Total RNA 
was extracted from the F-actin fraction by the guanidine-
phenol-chloroform method and submitted to real-time PCR. 
eEF1A protein was also measured in the F-actin fraction 
by immunoblotting (18).
Immunoblotting analysis
Thirty micrograms of protein from each sample was 
treated with Laemmli buffer (30), submitted to 10% SDS-
PAGE, and transferred to a nitrocellulose membrane by 
electroblotting for 60 min at 100 V. Nonspecific protein 
binding to the membrane was reduced by preincubation 
with blocking buffer (5% nonfat dry milk, 2.7 mM KCl, 137 
mM NaCl, 8 mM NaHPO4, 1.4 mM KPO4, and 0.1% Tween 
Table 1. PCR primers used in the present study. 
Primers Sequence
Antisense: proinsulin 5’-ACTTCACGACGGGACTTGGG-3’
Sense: proinsulin 5’-CAGGTCATTGTTCCAACATGGC-3’
Antisense: RPL19 5’-TCAGGCCATCTTTGATCAGCT-3’
Sense: RPL19 5’-CAATGAAACCAACGAAATCG-3’
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20) overnight at 4°C. The membrane was incubated with 
the monoclonal anti-ß-actin (1:5000) or anti-eEF1A (1:1000) 
antibody in blocking buffer, for 2 h at room temperature, 
followed by incubation with the appropriate secondary 
peroxidase-conjugated antibody (1:5000) in 2.7 mM KCl, 
137 mM NaCl, 8 mM NaHPO4, 1.4 mM KPO4, and 0.1% 
Tween 20 buffer, for 90 min at room temperature. After 
washing the membrane, bands were detected using the 
ECL kit. Blots were analyzed by scanning densitometry and 
quantified using the Image Master-1D-Pharmacia Biotech 
SW software (Pharmacia Biotech, Sweden). Membranes 
were also incubated with monoclonal anti-α-actinin antibody 
(1:1000), which was used as an internal control, under 
the same conditions as described above. The results are 
reported as AU normalized by α-actinin protein.
Statistical analysis
Data are reported as means ± SEM and were submit-
ted to one-way analysis of variance (ANOVA) followed by 
the Student-Newman-Keuls post-test. Differences were 
considered to be significant when P < 0.05.
Results
Thyroid hormone did not alter INS-1E cell viability 
The analysis of membrane integrity of INS-1E cells 
showed that the absence of TH or T3 treatment did not alter 
cell viability, since the percentage of control cells (89.62 ± 
2.05), hypothyroid (94.57 ± 0.67) or control cells treated 
with 1 µM T3 (95.96 ± 0.37), or 10 nM T3 (97.82 ± 1.96) 
with an intact plasma membrane did not change.
Proinsulin gene expression is decreased in 
hypothyroid pancreatic beta cells
The beta cells maintained in the hypothyroid condition 
had lower proinsulin mRNA levels compared to the control 
group. In contrast, control cells treated with T3 for 12 h 
did not show an alteration in proinsulin mRNA expression, 
which remained similar to those observed in the control 
group (Figure 1). 
Hypothyroidism decreases proinsulin mRNAs 
bound to the actin cytoskeleton
To determine proinsulin mRNA association with the 
cytoskeleton, G-actin and F-actin were separated by ultra-
centrifugation as described above. In the absence of TH, 
beta cells showed less proinsulin mRNA bound to the actin 
cytoskeleton; however, control cells incubated with T3 did 
not show an alteration of the amount of proinsulin mRNA 
anchored to the cytoskeleton (Figure 2). 
Hypothyroidism decreases the attachment rate of 
eEF1A to the actin cytoskeleton
eEF1A was also measured in the F-actin fraction after 
cytoskeleton fractionation. When pancreatic beta cells were 
maintained in the hypothyroid condition, there was a reduc-
tion of the eEF1A amount attached to the actin cytoskeleton 
when compared to the control group. 
In contrast, when the cells were incubated with T3 for 
12 h no significant change was observed in the amount of 
Figure 1. Hypothyroidism decreases proinsulin gene expres-
sion. INS-1E cells were divided into control (C), hypothyroid (Tx) 
and control plus T3 (1 µM or 10 nM T3) groups. Proinsulin gene 
expression was measured by real-time PCR and the values ob-
tained were corrected by RPL19. Data are reported as means ± 
SEM for three independent experiments (N = 4 per experiment), 
expressed in arbitrary units (AU). *P < 0.05 vs all other groups 
(one-way ANOVA followed by the Student-Newman-Keuls post-
test). 
Figure 2. Hypothyroidism decreases proinsulin transcripts an-
chored to the actin cytoskeleton. INS-1E cells were divided into 
control (C), hypothyroid (Tx) and control plus T3 (1 µM or 10 nM 
T3) groups. F-actin from the cytoskeleton was preserved and 
separated by ultracentrifugation. Total RNA was then extracted 
from the F-actin network, and proinsulin gene expression was 
measured by real-time PCR being normalized by RPL19 expres-
sion. Data are reported as means ± SEM for two independent 
experiments (N = 6 per experiment), expressed in arbitrary units 
(AU). *P < 0.05 vs all other groups (one-way ANOVA followed by 
the Student-Newman-Keuls post-test). 
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eEF1A attached to the actin cytoskeleton (Figure 3). 
The cytoskeleton remains unchanged after thyroid 
hormone treatment
G-actin and F-actin from the cytoskeleton were meas-
ured in the experimental and control groups. The amounts 
of the proteins were unchanged after TH withdrawal or T3 
addition. Data for F-actin (pellet fraction) are presented in 
Figure 4A and for G-actin (supernatant fraction) in Figure 
4B. 
Proinsulin poly(A) tail length remains unchanged 
after thyroid hormone treatment
The data obtained from RACE-PAT are shown in Fig-
ure 5. The poly(A) tail length of proinsulin transcripts from 
pancreatic beta cells did not change after TH withdrawal or 
T3 addition, being similar for the experimental and control 
groups.
Discussion
The present study shows that TH modulates proinsulin 
gene expression, since INS-1E cells cultured in its absence 
presented a decrease in proinsulin gene expression, as 
shown by the reduced amount of its transcripts. However, 
T3 addition to pancreatic beta cells in culture did not modify 
the amount of proinsulin mRNA. This differential modulation 
indicates that the presence of TH at physiological concentra-
tions is essential for the establishment of some biological 
Figure 3. Hypothyroidism decreases the amount of eEF1A pro-
tein anchored to the cytoskeleton. INS-1E cells were divided into 
control (C), hypothyroid (Tx) and control plus T3 (1 µM or 10 nM 
T3) groups. F-actin from the cytoskeleton was preserved and 
separated by ultracentrifugation. Proteins were then extracted 
from F-actin and submitted to electrophoresis and Western blot-
ting analysis for eEF1A, with the values obtained being normal-
ized by α-actinin. Blots of representative experiments are shown 
at the top of the figure. Data are reported as means ± SEM for 
two independent experiments (N = 6 per experiment), expressed 
in arbitrary units (AU). *P < 0.05 vs all other groups (one-way 
ANOVA followed by the Student-Newman-Keuls post-test). 
Figure 4. Thyroid hormone does not affect cytoskeleton rear-
rangement. Panels A and B show F-actin (pellet fraction) and 
G-actin (supernatant fraction), respectively. INS-1E cells were di-
vided into control (C), hypothyroid (Tx) and control plus T3 (1 µM 
or 10 nM T3) groups. Total actin protein content was determined 
by Western blotting and the values obtained were normalized by 
α-actinin. Blots of representative experiments are shown at the 
top of Figures A and B. Data are reported as means ± SEM for 
four independent experiments (N = 4 per experiment), expressed 
in arbitrary units (AU). No significant differences were observed 
between groups.
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processes, as demonstrated by proinsulin mRNA expres-
sion. Indeed, these data agree with reports that showed 
an increase of myostatin gene expression in hypothyroid 
rats, even though no changes in myostatin mRNA levels 
were detected in L-T4-treated rats (31). However, the 
mechanisms underlying these alterations, observed only 
in the hypothyroid condition, are unknown. 
RNAs are synthesized in the nucleus and exported to 
the cytoplasm, being addressed to specific regions inside 
the cells through cytoskeleton proteins (32,33). Transcripts 
are then attached to the cytoskeleton, which modulates 
their turnover rate and, consequently, the total amount of 
mRNA. Besides the alteration in proinsulin gene expression, 
the amount of its transcripts attached to the cytoskeleton 
is decreased in hypothyroidism, which might interfere with 
proinsulin mRNA stability, since the anchoring of mRNAs to 
the cytoskeleton increases or decreases transcript stability 
by a mechanism that most likely involves the regulation of 
the activity of specific RNases (34,35).
The interaction between transcripts and the cytoskeleton 
is a process mediated by proteins that bind to mRNAs, as 
well as to cytoskeleton proteins at different sites, at the same 
time. Several proteins are thought to possess this ability. In 
the present study, we evaluated the amount of eEF1A at-
tached to the cytoskeleton, since studies from our laboratory 
have shown that hypothyroidism decreases the association 
between eEF1A and actin in rat pituitary, an event promptly 
reversed after acute T3 administration (18).
Indeed, as shown in pituitaries from hypothyroid rats, 
the amount of eEF1A anchored to the cytoskeleton is 
reduced in pancreatic beta cells, suggesting that eEF1A 
may intermediate the anchoring of proinsulin transcripts to 
the actin cytoskeleton. It should be noted that the altera-
tions in proinsulin mRNA and eEF1A levels attached to 
the cytoskeleton are restricted to beta cells maintained in 
the hypothyroid condition, as these parameters were not 
changed after T3 treatment, reinforcing the importance 
of the euthyroid condition for the maintenance of normal 
proinsulin gene expression and its turnover. The fact that 
the attachment of both eEF1A and proinsulin mRNA to 
actin is decreased in the hypothyroidism condition does 
not necessarily indicate that these processes are directly 
linked, even though each one, per se, leads to the reduction 
of transcript stability, as described (18,21), and points to a 
post-transcriptional action of TH on the control of proinsulin 
gene expression.
Despite being the main structure for anchoring proinsulin 
transcripts and eEF1A, the cytoskeleton of the pancreatic 
beta cell is not altered after TH treatment since the amounts 
of G- and F-actin remain similar in the hypothyroid and 
hyperthyroid conditions. Hence, the decreased proinsulin 
mRNA and eEF1A content in the cytoskeleton fraction 
may indicate that hypothyroidism impairs the attachment 
of these molecules to the cytoskeleton, but it appears that 
these events are not associated with cytoskeleton disar-
rangement. 
Moreover, the cytoskeleton may be capable of interme-
diating the approach of transcripts to poly(A) polymerase, 
a process that leads to an increase in transcript poly(A) 
tail length by insertion of adenine residues. This process 
increases mRNA stability, as degradation of transcripts by 
RNases diminishes, enhancing the translation rate and 
protein accumulation (36). 
Despite the regulation of several transcript poly(A) tail 
length by TH, in the present study, the number of adenine 
residues in the proinsulin mRNA tail remained unaltered 
Figure 5. Thyroid hormone does not affect proinsulin transcript 
poly(A) tail length. The proinsulin mRNA poly(A) tail length was 
determined by rapid amplification of cDNA ends for the poly(A) 
test (RACE-PAT) in INS-1E cells divided into control (C), hypo-
thyroid (Tx) and control plus T3 (1 µM or 10 nM T3) groups. The 
smearing pattern of ethidium bromide-stained PCR products 
obtained by RACE-PAT is shown at the top of the figure. The 
horizontal line delimits the heaviest PCR fragments generated in 
the samples. The maximal size of the amplicons, corresponding 
to the top of the smear of each sample (in bp), is shown at the 
top. Data are reported as means ± SEM for two independent ex-
periments (N = 3 per experiment), expressed in bp. No significant 
differences were observed between groups. RACE-PAT = rapid 
amplification of cDNA ends - poly(A) test.
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in cells cultured in hypothyroid medium as well as after 
T3 treatment, which indicates that TH regulates proinsulin 
mRNA stability probably by anchoring the transcripts to the 
cytoskeleton, without involvement of the poly(A) tail.
The data presented here show that at least part of the 
modulation of proinsulin gene expression by TH seems 
to occur at the post-transcriptional level, since proinsulin 
mRNA turnover depends on the attachment of proinsulin 
transcripts and eEF1A to the cytoskeleton, which is a 
biological process that occurs after the gene transcription, 
interfering with insulin production by the cells. However, 
we cannot rule out the possibility that TH might act physi-
ologically inducing proinsulin gene transcription. These data 
should be considered when the action of TH on carbohydrate 
metabolism is under investigation.
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